Hualan Biological Vaccine Inc. (SHE: 301207)
China
· Delayed Price · Currency is CNY 19.68
-0.45 (-2.24%)
Nov 15, 2024, 3:04 PM CST
Hualan Biological Vaccine Company Description
Hualan Biological Vaccine Inc. engages in the research, development, production, and sale of vaccines in China.
It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, H1N1 influenza virus split vaccines, ACYW135 meningococcal polysaccharide plague vaccines, recombinant hepatitis B vaccines, and group A and C meningococcal polysaccharide vaccines, as well as genetic engineering vaccines for human use.
The company was founded in 2005 and is based in Xinxiang, China.
Hualan Biological Vaccine Inc.
| Country | China |
| Founded | 2005 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 770 |
| CEO | Wenjue An |
Contact Details
Address: No. 1-A-1, Hualan Avenue Xinxiang, 453003 China | |
| Phone | 86 37 3355 9991 |
| Website | hualanbacterin.com |
Stock Details
| Ticker Symbol | 301207 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000058J9 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Wenjue An | GM and Director |
| Ruowen Pan | Deputy GM and Director |